Leading Venture Development Group in Arizona Kicks Off Nationwide Search for the Most Promising Healthcare IT StartupsContinue reading
Author Archive: AZBio
W.L. Gore & Associates, Inc. Named 2013 Arizona Bioscience Company of the Year
W.L. Gore & Associates will be honored at the 2013 AZBio Awards as the Arizona Bioscience Company of the Year by the Arizona Bioindustry Association in recognition of the development of the extensive Gore Medical family of products including vascular grafts, endovascular and interventional devices, and surgical meshes by its world class team of innovators in Flagstaff and Phoenix. Continue reading
GMSBiotech and NuvOx presenting at National Heart, Lung, and Blood Institute San Francisco Innovation Conference
The National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute’s (NHLBI) San Francisco Innovation Conference co-hosted by Prescience International, a firm dedicated to accelerating the commercialization and global adoption of science and technology will bring together small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries onSeptember 10, 2013 at the Genentech Hall at U C San Francisco.Continue reading
Genentech’s Scheller and Stanford’s Südhof to receive the 2013 Albert Lasker Basic Medical Research Award
Richard H. Scheller and Thomas C. Südhof to be honored for discoveries concerning the molecular machinery and regulatory mechanism that underlie the rapid release of neurotransmitters.
Continue reading
Something to Smile About – Nasseo takes its place in the AZBio Fast Lane
Nasseo, Inc. selected to receive the 2013 AZBio Fast Lane Award from the Arizona Bioindustry Association for its accelerated progress in the development of new dental and orthopedic implant technology.Continue reading
FDA approves drug tested by Scottsdale Healthcare and TGen
Abraxane now part of standard-of-care for patients with advanced pancreatic cancer, following studies at the Virginia G. Piper Cancer Center at Scottsdale Healthcare
Continue reading
NAU President John Haeger outlines succession plans
September 5, 2013 : Northern Arizona University – After 12 successful years as president of Northern Arizona University, John D. Haeger announced today that the lengthy process to search for his successor will begin soon.Continue reading
Opportunity Alert – Driving Innovation in Breast Cancer: Startup Challenge
The Avon Foundation (AF), National Institutes of Health National Cancer Institute (NCI) and Center for Advancing Innovation (CAI) have partnered to launch a “first of a kind” Business Plan and Start-Up Challenge for Breast Cancer (BC) inventions that have high commercial viability and are important to public health. This challenge will accelerate the commercialization of Federal agency and AF grantee BC inventions, spur economic growth, and provide Universities a platform to further develop their entrepreneurship learning portfolio.Continue reading
U.S. Food and Drug Administration Approves ABRAXANE® in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer
-Approval Based on MPACT Study of ABRAXANE in Combination with Gemcitabine Demonstrating a Clinically Meaningful Increase in Overall Survival-
-First New Treatment Approved for Metastatic Adenocarcinoma of the Pancreas in Nearly 8 Years-Continue reading
NIH Awards HTG Molecular Additional $1.01M to Continue Development of Targeted Sequencing Product Concept
TUCSON, AZ–(Marketwired – Sep 4, 2013) – The National Human Genome Research Institute of the National Institutes of Health issued a Notice of Award granting a Phase II SBIR award of $1.01 million for HTG Molecular Diagnostics to continue the Nuclease Probe Mediated Sequencing Project (HTG EdgeSeq). The HTG EdgeSeq program will develop targeted sequencing products that leverage HTG Molecular Diagnostics’ core RNA analysis technology.Continue reading